|
|
 |
|
Viewing report
|
|
|
|
Cost Rationalization in Pharmaceutical Production
Business Horizons, Jan 2010, Pages: 112
The pharmaceutical industry is facing increasing pressure to reduce costs, in order to remain competitive. This can be achieved through a variety of ways like cost reduction through sustainable manufacturing strategies, developing a streamlined and consistent global supply network, identifying global suppliers and controlling COGS throughout the product development and manufacturing lifecycle. With low-cost manufacturing, high-quality research and manufacturing facilities and educated personnel, the Indian pharmaceutical industry presents both a competitive threat and partner opportunities. This has resulted in increasing its manufacturing capability to competetive international levels, so that it is fast emerging as a sourcing partner for international pharma majors. India now has the largest number of US FDA approved plants outside the USA and boasts of permanent facilities of USP and US FDA due to the large number of regulated pharma manufacturing facilities.
This book for the first time provides a rare insight into the nitty-gritty workings of Indian pharma companies, how they have managed to bring down the cost of manufacturing to surprisingly low levels while maintaining compliance with world regulatory authorties. With the unique angle of supply chain opportunities, this book provides a scientific study of cost rationalization in production giving numerous examples, case studies, tables/charts and illustrations. Pharmaceutical companies worldwide can now tap into the management resources of Indian pharma companies for obtaining unique cost leverage and control cost of production. This is a very focussed and coincise book dealing exclusively for the first time on cost rationalization in pharmaceutical production through the route of supply chain gaps and opportunities.
Product samples
A sample for this product is available. Please Login/Register to download this sample.
Customers who bought this item also bought
Comparisons of Pharmaceutical Manufacturing between China and India
Pharmaceuticals - Global Outlook
Strategies for Managing Pharmaceutical Workforce and Site Reductions: Analysis of Legal, Productivity, and Quality Control Issues
Big Pharma’s New Licensing Strategies
The Top 10 CMOs in India: Market Dynamics, Competitive Positioning and Trends
Opthalmic Pharmaceutical Drugs - Global Strategic Business Report
The New Trends of Global Pharmaceutical Outsourcing: New Developments in Strategy, Market, Service and Technology
Pharmaceutical Cliff Diving - Assessing the Key Challenges that will Re-Shape the Industry
Radio Frequency Identification (RFID) in Pharmaceuticals - Supply Chain Security Concerns Provide Impetus for RFID Adoption
Indian Pharmaceutical Industry, Q4 2011
|
|
|
|
